Uncategorized

November 18, 2026

More Details as Available

SWD Urethane

November 11, 2026

U.S. Mattress Industry Overview

Domestic mattress industry: Fewer beds, bigger players, a battle for share

Sheila Long O’Mara// Executive Editor, Furniture Today//November 9, 2026

  • At a Glance:
  • Somnigroup acquires Mattress Firm and Leggett & Platt
  • Imported mattress value drops over 40% after 2024 antidumping orders
  • South Bay International controls Corsicana and Englander brands

HIGH POINT — The domestic mattress industry is getting smaller, but the stakes for the manufacturers still standing have never been higher.

With fewer mattresses being sold, consolidation reshaping the competitive landscape and low-priced imports capturing an increasingly significant share of the market, domestic producers are confronting a fundamental question: How to compete in a business that looks dramatically different than it did just five years ago?

For some, the answer is moving upmarket. Others are investing in vertical integration, doubling down on domestic production or finding new ways to reach consumers before they ever walk into a mattress store.

The numbers back them up. The U.S. mattress and foundation market shipped 13.2% fewer units in 2025, while its wholesale value fell a smaller 6.5%, to $9.25 billion, according to the International Sleep Products Assn. The value of imported mattresses has dropped by more than 40% in two years, according to U.S. International Trade Commission data, after a second wave of antidumping orders took effect in 2024.

Ownership is becoming more concentrated.

Somnigroup International, parent of Tempur-Pedic, Sealy and Stearns & Foster, acquired the nation’s largest mattress specialty retailer, Mattress Firm, in February 2025. In August 2026, it closed its purchase of its biggest component supplier, Leggett & Platt.

South Bay International now controls Corsicana and the Englander brand. And, Amazon sits as the country’s No. 2 bedding retailer, behind only Mattress Firm, by Furniture Today’s estimate.

“The industry as a whole is struggling,” said Gerry Borreggine, CEO of Therapedic Worldwide. “Some companies are doing great; some are struggling. There’s a lack of customers; there are good months, and there are bad months.”

Others were steadier. Mlily USA Chief Operating Officer Kyle Robertson called the domestic manufacturing business “stable,” and South Bay International CEO Toby Konetzny described a return to a normal, cyclical market after the pandemic’s “non-normal event.”

What no one disputed is that domestic producers are competing on new terms. Duties have helped at the border, but low-priced online imports, some of which fail federal flammability standards, set the price expectations for a large share of shoppers.

Makers are responding by moving upmarket, investing in vertical integration and trying to win consumers’ attention before they ever reach a store, including in AI search.

The total U.S. market for mattresses and stationary foundations was worth $9.25 billion at wholesale in 2025, down from $9.9 billion in 2024, according to ISPA’s Mattress Industry Trends Report. Those figures include imports and are based on a survey of U.S. manufacturers.

The gap between dollars and units is the defining feature of the category.

“Fewer units sold; higher average unit selling price on domestic mattresses,” said Laure Tokarz, president of Restonic Mattress, adding that the shoppers who left the domestic mix are largely at the bottom of the price ladder.

“The $399 and under consumer has turned to online retailers for their mattress,” she said. “The luxury customer continues to shop in stores and values that relationship.”

The decline was broad. Every U.S. region shipped fewer mattresses and foundations in 2025. The South remained the largest region, accounting for about 42% of the dollar value and 45% of the units of U.S.-produced goods.

South Bay’s Konetzny cautioned against measuring today’s market against the pandemic peak. He called that buying surge a “non-normal event” that gave the industry a selling season unlike any other. Now, he said, the business has returned to its normal pattern of cyclical sales events, with ups and downs.

Duties shrank imports’ dollars, not reach

The value of imported mattresses has fallen by 40.8% since 2023, according to USITC figures. Most of that drop came in 2024, the year the latest antidumping orders took effect.

The timing lines up with trade enforcement.

The U.S. Commerce Department issued antidumping orders on mattresses from Bosnia and Herzegovina, Bulgaria, Burma, Italy, the Philippines, Poland, Slovenia and Taiwan on July 11, 2024. Orders on India, Kosovo, Mexico and Spain followed on Sept. 10, 2024. Those cases came on top of an earlier antidumping order on mattresses from China, which the USITC reviewed in 2025. A companion countervailing duty case for Indonesia did not result in an order.

The 2024 import decline outpaced the overall market’s decline, which suggests the duties, not only weak demand, reshaped sourcing.

ISPA’s reading of 2025 is more cautious. Its report found that imported unit volume declined modestly while average values per unit fell more sharply, and that import activity grew in parts of Southeast Asia and Africa. The top 2025 sources by units were Indonesia, Vietnam and Mexico, out of 35 countries of origin, according to ISPA. Indonesia, the one country in the 2023 petitions that avoided duties, is now the largest source.

In other words, the duties shrank the dollars flowing to imports but not necessarily their unit footprint. Leggett & Platt estimates that imports grew from about 10% of U.S. mattress units a decade ago to more than 40%.

A note on comparison: USITC figures are customs values, which exclude duties, freight and importer markup, so they understate imports’ share of ISPA’s wholesale total.

Manufacturers said the duties have helped, but with limits.

“Tariffs are helpful for U.S. manufacturing,” said Robertson of Mlily USA. He said holes remain, with importers continuing to cross-ship product through other friendly countries to avoid tariffs or find lower rates. “We want a level playing field. It’s only as level as what the government can enforce.”

Robertson also tied the duties to a new problem. “Since the antidumping cases, we’ve seen an increase in fly-by-night brands pop up online. Some don’t meet the flammability standards U.S. manufacturers must adhere to. There is no product equity there.

“I don’t think imports are inherently bad, but we have seen some bad actors that don’t follow the rules,” he said.

Ongoing consolidation

The biggest structural change in domestic mattress manufacturing is not happening at the border. It is happening on the balance sheet.

“It’s an interesting time to be in this category right now with the ongoing consolidation,” Borreggine said. He traced the line from the Tempur-Pedic and Sealy merger to Mattress Firm to Somnigroup’s acquisition of Leggett & Platt, as well as other mergers throughout the industry.

Somnigroup completed its roughly $5.1 billion acquisition of Mattress Firm last year. Earlier this year, it completed its all-stock acquisition of Leggett & Platt, valued at about $2.3 billion at closing. Leggett will operate as a new reporting segment.

Within a week of closing, Somnigroup outlined plans that included branded innersprings, new component standards at Mattress Firm and bringing more of its spring production in-house.

Independent producers are already planning around that. “Because of Somnigroup’s acquisition of Leggett, we will see more importing of coils, or we’ll see manufacturers begin making their own coils so that they can control their own destiny,” said Tokarz.

At the value end of the market, South Bay has been the most active consolidator. It acquired the operating assets of Corsicana Mattress Co. a year ago, in a going-concern sale that preserved about 60% of Corsicana’s workforce.

It has since put the Englander brand under the same ownership. A South Bay affiliate acquired full ownership of Englander Sleep Products, and Corsicana will now make all U.S. Englander mattresses, replacing the brand’s network of independent regional licensees.

Konetzny said he expects ongoing consolidation.

“We do have some manufacturers with a noose around their necks right now,” he said. “If it gets tighter, they’ll sell. This is only the turn, and more mergers and acquisitions will occur. The pie remains the same size; it’s just that there are less of us splitting it.”

For a growing share of shoppers, buying a mattress has become one click. The price is right, and delivery is quick. Domestic makers say that convenience is teaching consumers to shop on price rather than performance and that some of what they buy is not legal to sell.

While Amazon does not disclose its mattress sales, Furniture Today estimated its 2024 bedding sales (mattresses, foundations and adjustable bases) at $3.1 billion, second behind Mattress Firm’s estimated $3.26 billion. The online retailer’s strength is at the low end where it dominates the $500-and-under mattress segment.

“Amazon takes a ton of units out of the marketplace, but the life expectancy of those mattresses is short,” said Richard Fleck, president of Paramount Sleep. “The disposable mentality is massive right now.”

The category, he said, is teaching consumers about price behavior, not performance.

Konetzny said economics are pushing the bottom of the market online. The cost to deliver a $199 mattress, given freight, fuel and labor, isn’t worth the sale for many traditional producers, he said.

Getting vertical

3Z Brands is among the competitors reshaping the market, and its investment is hard to miss.

The company recently completed a 280,000-square-foot expansion of its main plant in Glendale, Ariz., bringing the facility to 965,821 square feet of manufacturing space. The addition adds foam curing and storage capacity, as well as a molded pillow operation. 3Z pours its own foam and makes its own coils, and it operates plants in Glendale and Phoenix, Oklahoma City and Nashville, Tenn.

FXI is building on a broad U.S. footprint of its own. Its 424,000-square-foot factory in Auburn, Ind., makes its Molecule brand products and is one of about 20 domestic facilities the company operates.

“The flywheel is turning, as we continue to expand our footprint with key retailers,” said Mike Juoni, vice president of specialty bedding sales for FXI, who helps lead the Molecule brand.

Juoni sees two paths ahead for domestic production. “The big guys will continue doing what they do. The smaller companies have to get sharper and become more innovative in their product and the approach they take to the business.

“Despite the economic indicators pointing against us, retailers and manufacturers are finding ways to win.”

Paramount made its choice more than a decade ago. “We have chosen to play at higher price points,” Fleck said.

The sub-$1,000 business is online, he said, and that is not where the company wants to compete. “That’s a journey we started in 2014, and we’re sticking to our knitting at the better, premium price points.”

Mlily USA remains committed to its domestic footprint. “We’re committed to producing mattresses for the domestic market in the U.S.,” Robertson said.

The company has been shifting some production of mattresses, toppers and pillows to its Arizona facility since earlier this year. A major fire this summer at the Healthcare factory in South Carolina where some of its products were made accelerated that timeline.

“Made in the USA is a cornerstone of our strategy for the domestic market,” Robertson said. “The made in the USA tag only has cachet in the States right now. Historically, that had never been an issue, but the mindset shifted since the pandemic and the current isolationist approach.”

He also noted that politics weigh on consumer confidence, which remains tough as shoppers struggle with high gas and grocery prices.

DeRucci USA is taking a hybrid approach to sourcing for an AI-powered sleep system, said Guy Ray, CEO of DeRucci North America. Components come from Asia and the mattress is assembled in the U.S. Ray said that model works for a bed that will retail for $8,499 in queen and begin shipping in February.

Few expect a quick rebound. ISPA’s February 2026 outlook called for a near-flat market in 2026, after its earlier forecasts overestimated 2025.

Asked to look five years out, executives largely described the same landscape: fewer, larger manufacturers and retailers, with smaller players surviving by specializing.

Konetzny’s advice to the companies that remain was blunt. “If your big business plan is to wait for business to get better, you’re in trouble,” he said. “We are laser-focused on success across all our brands.

https://www.furnituretoday.com/mattress-bedding-news/domestic-mattress-industry-fewer-beds-bigger-players-a-battle-for-share

November 2, 2026

Huntsman Q3 Results

Huntsman Announces Third Quarter 2026 Earnings

Download as PDFNovember 02, 2026 4:15pm EST

Third Quarter Highlights

  • Third quarter 2026 net loss attributable to Huntsman of $18 million compared to a net loss of $25 million in the prior year period; third quarter 2026 diluted loss per share of $0.10 compared to diluted loss per share of $0.14 in the prior year period.
  • Third quarter 2026 adjusted net income attributable to Huntsman of $7 million compared to adjusted net loss of $5 million in the prior year period; third quarter 2026 adjusted diluted income per share of $0.04 compared to adjusted diluted loss per share of $0.03 in the prior year period.
  • Third quarter 2026 adjusted EBITDA of $132 million compared to $94 million in the prior year period.
  • Third quarter 2026 net cash provided by operating activities from continuing operations was $115 million. Free cash flow was $82 million for the third quarter 2026 compared to $157 million in the prior year period.
  • On August 25, 2026, Huntsman shareholders approved the merger of equals with Olin Corporation. Once the merger is completed, the combined OlinHuntsman will trade under a new ticker, NYSE: OHN.
Three months endedNine months ended
September 30,September 30,
In millions, except per share amounts2026202520262025
Revenues$     1,717$     1,460$     4,800$     4,328
Net loss attributable to Huntsman Corporation$         (18)$        (25)$        (77)$      (188)
Adjusted net income (loss)(1)$            7$          (5)$        (28)$        (58)
Diluted loss per share$      (0.10)$     (0.14)$     (0.44)$     (1.09)
Adjusted diluted income (loss) per share(1)$       0.04$     (0.03)$     (0.16)$     (0.34)
Adjusted EBITDA(1)$        132$         94$        325$        240
Net cash provided by operating activities from continuing operations$        115$        200$            2$        221
Free cash flow(2)$          82$        157$        (99)$        105
See end of press release for footnote explanations and reconciliations of non-GAAP measures.

THE WOODLANDS, Texas, Nov. 2, 2026 /PRNewswire/ — Huntsman Corporation (NYSE: HUN) today reported third quarter 2026 results with revenues of $1,717 million, net loss attributable to Huntsman of $18 million, adjusted net income attributable to Huntsman of $7 million and adjusted EBITDA of $132 million. 

Peter R. Huntsman, Chairman, President, and CEO, commented:

“Our Company continues to perform solidly despite significant macroeconomic and industry challenges. Year-over-year improvement was driven by higher volumes, stronger margins, and cost savings. Better results and cash flow are expected to reduce net debt leverage to approximately 4 times by year-end, a significant improvement from the beginning of the year. These gains reflect our associates’ hard work and disciplined execution to grow volumes, lower costs, and generate cash.

“Our planned merger of equals with Olin Corporation reached several milestones during the quarter, including shareholder approval on August 25, 2026, and regulatory clearance in multiple jurisdictions, including the United States in September. We continue to work with the remaining jurisdictions to secure the approvals needed to complete the merger, which we now expect to close in the first quarter of 2027. We are excited about the benefits the merger will bring to both companies’ shareholders.”

Segment Analysis for 3Q26 Compared to 3Q25

Polyurethanes

The increase in revenues in our Polyurethanes segment for the three months ended September 30, 2026 compared to the same period of 2025 was primarily due to higher average selling prices and higher sales volumes. MDI average selling prices increased across all three regions due to improved supply and demand dynamics and higher raw materials costs. MDI sales volumes increased in the Americas and Europe regions. The increase in segment adjusted EBITDA was primarily due to higher average selling prices, higher sales volumes, higher equity earnings from our minority-owned joint venture in China and cost savings achieved from our cost optimization program, partially offset by higher raw materials costs.

Performance Products

The increase in revenues in our Performance Products segment for the three months ended September 30, 2026 compared to the same period of 2025 was primarily due to higher average selling prices. Average selling prices increased primarily due to higher raw materials and logistics costs and favorable sales mix. Sales volumes remained relatively unchanged. The increase in segment adjusted EBITDA was primarily due to higher average selling prices and improved margins.

Advanced Materials

The increase in revenues in our Advanced Materials segment for the three months ended September 30, 2026 compared to the same period of 2025 was primarily due to higher sales volumes and higher average selling prices. Sales volumes increased primarily in our aerospace, automotive and power markets. Average selling prices increased primarily due to favorable sales mix. The increase in segment adjusted EBITDA was primarily due to higher sales volumes.

Liquidity and Capital Resources

During the three months ended September 30, 2026, our free cash flow was $82 million as compared to $157 million in the same period of 2025. As of September 30, 2026, we had approximately $0.9 billion of combined cash and unused borrowing capacity.

During the three months ended September 30, 2026, we spent $33 million on capital expenditures as compared to $43 million in the same period of 2025. During 2026, we expect capital expenditures to be approximately $160 million.

Income Taxes

In the third quarter of 2026, our effective tax rate was 108% and our adjusted effective tax rate was 56%.

Earnings Conference Call Information

We will hold a conference call to discuss our third quarter 2026 financial results on Tuesday, November 3, 2026, at 9:00 a.m. ET.

Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=oRyBrBjV

Savor this one, it could be the last . . .

https://www.huntsman.com/news/media-releases/detail/635/huntsman-announces-third-quarter-2026-earnings

March 1, 2026

Recticel Leadership Changes

Recticel Group Announces Leadership Transition


Jan Vergote to transition from CEO to Executive Chairman of the Board of Directors and Stefaan Debusschere to become Recticel Group CEO


Today, Recticel Group announces that Stefaan Debusschere, currently CEO of the Recticel Insulation Boards Division, is transitioning to Chief Executive Officer of the Recticel Group. At the same time, Jan Vergote, current Chief Executive Officer, will assume the role of Executive Chairman of Recticel Group. In order to allow and support these changes, Wim Dejonghe will step down as Chairman and will leave the Board of Directors after almost 2 years of service in a period of strategic reorientation and above-market growth.

The above changes take effect on 2 March 2026. As Stefaan Debusschere, Jan Vergote and Wim Dejonghe, have been working closely together over the past months, this transition is well prepared.


Wim Dejonghe:

“This leadership evolution comes at a time where Recticel will further accelerate the execution of its strategic growth agenda to double the company’s size and profitability in its core mission of providing smart building insulation solutions. I am convinced that Stefaan’s entire leadership team, and Jan as our incoming Executive Chairman are ready and highly motivated to achieve the plan.”


Jan Vergote:

“Our ambition is to build a smart building insulation group capable of outperforming the market. With revenue and adjusted EBITDA growth of respectively 23% and 42% over the last 2 years, and with the recent acquisitions and greenfields, we are ready for the next step. I will actively support Stefaan and his team to accelerate the development of our strategic agenda.”


Stefaan Debusschere:
“At Recticel, I have found a leadership team that matches a high level of competence with true entrepreneurial spirit. I am committed to implement the strategic agenda, Recticel Group’s Elevate 2030 plan, with focus on operational excellence, leadership involvement with key customers, a deeper presence in downstream applications and a stronger focus on the development of high performance insulation, whilst creating a broader geographical scope.”

Find out more on www.recticel.com.

March 1, 2026

Urethane Highlights from BASF Call

BASF SE (BASFY) Q4 2025 Press Conference Call Transcript

Feb. 27, 2026 11:28 AM ETBASF SE (BASFY) Stock, BFFAF Stock

BASF SE (BASFY) Q4 2025 Press Conference Call February 27, 2026 4:30 AM EST

Company Participants

Andreas Meier
Markus Kamieth – CEO & Chairman of the Board of Executive Directors
Dirk Elvermann – Member of the Board of Executive Directors, CFO & Chief Digital Officer

Markus Kamieth
CEO & Chairman of the Board of Executive Directors

[Interpreted] Thank you, Andreas. Good morning, and welcome to Ludwigshafen, and also to those in front of the monitors. First of all, thank you, Andreas, for you, for having taken over this job. You are doing this for the first time or have been doing this for the first time for a long time because Nina Schwab-Hautzinger left to join Roche, but you probably heard yesterday that we will welcome Thomas Biegi as successor of Nina Schwab-Hautzinger soon. And I think in future, he will take this job, but well, you will have to agree with him.

Dirk Elvermann and I will present and explain the most important figures and developments of the 2025 business year. 2025 marked by many geopolitical and headwinds in the world that unfortunately had a negative impact. Consequently, we, in the chemical industry, faced an uncertain and very volatile global market environment and with considerable headwinds. As previously stated, we, therefore, focus primarily on the things we can control within the framework of our Winning Ways strategy.

We successfully started up the major assets at our new Verbund site in Zhanjiang, and we also accelerated our cost savings programs and significantly streamlined BASF’s organization. Moreover, we progressed swiftly and successfully with the announced portfolio measures. But let me also mention that the year 2025 and particularly the fourth quarter did not develop as we had anticipated. Our prerelease on January 22 already gave you an indication of this.

Let’s now turn to the details of BASF’s financial performance in the fourth quarter of 2025, always compared with the prior year quarter. Overall, sales declined considerably because of strong currency headwinds and slightly lower prices. At the same time, we achieved slightly higher volumes. All segments reported volume growth, except for the Chemicals segment. Volumes rose particularly in Surface Technologies, Agricultural Solutions and Nutrition & Care segments.

From a regional perspective, we achieved a remarkable volume increase of 13% in China and posted solid growth in North America. In Europe, we recorded slightly lower sales volumes. Compared with the fourth quarter of 2024, prices declined in 5 of our 6 segments, most notably in Chemicals and Materials due to ongoing competitive pressure. We could only increase prices in the Surface Technologies segment, primarily owing to higher precious metal prices. Currency effects burdened sales in all divisions and were mainly caused by the strong depreciation of the U.S. dollar, the Chinese renminbi and Indian rupee. Portfolio effects slightly dampened sales growth, and this was mostly related to the sale of our Decorative Paints business.

Based on this underlying sales development, EBITDA before special items came in at EUR 1 billion compared with EUR 1.4 billion in the prior year quarter. Currency headwinds lowered EBITDA before special items in the fourth quarter of 2025 by around EUR 110 million. Ladies and gentlemen, overall, BASF Group’s EBITDA before special items reached EUR 6.6 billion in the full year of 2025. The decline compared with 2024 was mainly due to lower margins and negative currency effects, and the latter amounted to EUR 235 million in the full year 2025. Due to continued low market demand and pressure on margins, earnings in BASF’s core businesses, especially in the Chemicals segment, declined considerably. Higher contributions from BASF’s stand-alone businesses could only partially compensate for this decrease.

Let’s now turn to our portfolio measures. Our agreement with Carlyle marks an important milestone in realizing the full value of our Coatings business. Prior to that, we had divested our Decorative Paints business to Sherwin-Williams. Under Carlyle’s operational leadership, we want to continue to strengthen the leading position of the Coatings business. This will create further upside potential for the 40% equity share we will continue to hold after closing. We are on track to close the transaction in the second quarter, as previously announced. On the basis of the 2 transactions, BASF’s Coatings business is valued at an enterprise value of EUR 8.7 billion.

Let’s move on to Agricultural Solutions. Our team here once again delivered a very strong performance in 2025 and achieved an EBITDA margin before special items of 22%. We are on track to reach IPO readiness in 2027. Last year, excellent progress was made on the legal entity and ERP separation. By early 2027, the separation will be completed in all regions.

In November, we announced the future management Board for the Ag business. Its members combine extensive industry expertise with the required capital market experience. The management team headed by Livio Tedeschi will drive the transformation of Ag Solutions into an independently steered company focusing solely on the agricultural sector. The planned listing of our Agricultural Solutions business will mark the next decisive step to unlock additional value for our shareholders. The planned IPO is targeted to take place on the Frankfurt Stock Exchange.

And what is also good news is another piece of news. In January, we announced that BASF Agricultural Solutions is acquiring AgBiTech, a supplier of biological solutions to control insect pests. It has pioneered the use of nucleopolyhedrovirus technology to develop insect control solutions based on naturally occurring viruses. With operations in Brazil, the United States and Australia, AgBiTech serves farmers growing soybean, corn, and cotton as well as specialty crops. This acquisition is an important step in the value creation journey of Agricultural Solutions. The new technology will complement BASF’s existing biosolutions portfolio and underscores the commitment to a more sustainable, holistic approach in agriculture, in line with the business strategy of Ag Solutions. The transaction is expected to close in the first half of 2026.

From the stand-alone Ag business, let’s return to the beginnings of our value chain. We successfully started up all 32 key production lines at our Zhanjiang-Verbund site on time and below budget, a remarkable achievement and a testament to the capabilities of our teams. We also started up the steam cracker, the heart of the Verbund, without any lost time. This steam cracker is flexible, so we can use both naphtha and butane as feedstocks.

I was very pleased to hear Linde’s CEO, Sanjiv Lamba, describe this as one of the fastest cracker starts up ever. Linde supports us with their cracker technology and engineering expertise and contributed to this major achievement of our teams in Zhanjiang. The team executed this complex task with outstanding dedication and success. We are confident that we will operate the site at high utilization rates even in the current market environment. Nevertheless, I want to note that we expect a slightly negative earnings contribution from the Zhanjiang-Verbund site in the first year of operations, mainly due to start-up related costs. From 2027, we expect the site to contribute positive earnings.

Ladies and gentlemen, MDI is an important product for BASF and a key component of our polyurethane value chain. It is indispensable in the construction, automotive, coatings, adhesives and furniture sectors. Classic applications include rigid and flexible foams. It can be found as insulation and upholstery material in your car. For example, I think you’re not sitting on such a chair at the moment. In the United States, we are currently expanding our MDI plant in Geismar, Louisiana. The final phase is on track, and we are planning to start up production in the third quarter of 2026. At USD 1 billion in total, the project marks BASF’s largest investment ever in the United States. Through this expansion, we are doubling our MDI capacity in Geismar to around 600,000 metric tons per year to serve the growing U.S. market.

Dirk Elvermann
Member of the Board of Executive Directors, CFO & Chief Digital Officer

Ladies and gentlemen, where do we stand with BASF’s cost-saving programs? In a nutshell, we have accelerated the implementation. By the end of 2025, we already achieved a total annual cost reduction run rate of around EUR 1.7 billion, and this represents an increase of EUR 100 million compared with our original savings target for this date. In 2025, the associated onetime costs amounted to EUR 700 million, and this increase in onetime costs of around EUR 300 million was caused by higher provisions for severance payments. In contrast, the planned onetime costs for 2026 will be reduced from EUR 500 million to EUR 300 million. By the end of 2026, we now expect annual cost savings of EUR 2.3 billion instead of EUR 2.1 billion as planned. The cumulative onetime costs are now expected to amount to EUR 1.9 billion in total. And this shows our positive momentum in bringing down our cost base and our ongoing focus on this crucial topic that we are dedicated to.

On the right-hand side of this slide, you can see that between December 2023 and December 2025, we reduced the number of BASF senior executives by 11%. The number of employees decreased by 4,800 if we exclude the around 1,000 employees who were recruited at the Verbund site in China in the same period. This demonstrates that we are actively streamlining our global organization at all levels. In 2026, we will further advance in this direction.

We recently communicated our next steps to create more value, which will happen in BASF’s service organizations. And these are Global Digital Services and Global Business Services. Why are we doing this? Against the backdrop of our successful portfolio measures and the differentiation between core and stand-alone businesses, we now also want to streamline IT, finance and HR services to meet the needs of BASF’s core businesses. In Global Digital Services, we are rationalizing and harmonizing BASF’s IT application landscape and sharpening the Digital Service portfolio through consolidation and standardization. In this context, we plan to open a cost-efficient digital hub in Hyderabad, India. We will adjust our existing location footprint and take out significant costs.

Building on competitive service levels and focused digitalization, these measures allow us to capture efficiency gains and achieve a significant reduction in the Digital Services workforce. Similarly, in Global Business Services, we intend to streamline the service portfolio, drive automation and establish cost-efficient global hubs. We, therefore, aim to bundle a significant portion of our business services in 2 global hubs in Asia. At the new global hub in India, we intend to bundle services with a focus on finance and HR. And the established hub in Kuala Lumpur in Malaysia is foreseen to focus on global supply chain services in the future. Existing regional hubs will complement this setup.

Markus Kamieth
CEO & Chairman of the Board of Executive Directors

[Interpreted] Thank you, Dirk. A key objective of our Winning Ways strategy is attractive shareholder distributions via dividends and share buybacks. That is why we will propose a dividend of EUR 2.25 per share for the 2025 business year to the Annual Shareholders’ Meeting. Based on the year-end share price, this represents an attractive dividend yield of 5.1%. The second pillar of our attractive shareholder distribution policy is our buyback program. In view of cash proceeds already received and further proceeds expected, particularly from portfolio measures, we started buying back shares in November 2025. By year-end 2025, we had repurchased shares of around EUR 355 million.

Moving on to our outlook for 2026. From today’s perspective, we do not expect a meaningful market upswing or a significant easing of geopolitical tensions in the near term. Our forecast for the BASF Group assumes that GDP growth will be slightly lower and that global industrial production growth will be significantly lower than the 2025 level. We expect a further decline in chemical production in the mature economies and weaker growth in the emerging markets.

Our planning is based on an average oil price of USD 65 per barrel of Brent crude and an exchange rate of $1.20 per euro. Based on these assumptions, we expect EBITDA before special items to be between EUR 6.2 billion and EUR 7 billion in 2026. BASF Group’s free cash flow is expected to be between EUR 1.5 billion and EUR 2.3 billion. Payments made for property, plant and equipment and intangible assets are estimated to be reduced to EUR 3.4 billion.

I’d like to add that from a market perspective, the start to the first quarter has been as challenging as expected. In January, volumes in China continued to develop very positively, which is partly related to the timing of the Chinese New Year. But in the remaining regions, volume development has been weak. Given the considerably stronger U.S. dollar in the prior year quarter, currency headwinds on EBITDA before special items could amount to up to EUR 200 million in the first quarter of 2026 alone. So 2026 is likely to be another transitional year with significant headwinds for our industry. Most of the improvements we aim to achieve will need to be driven by our own efforts. We expect a gradual recovery of market conditions in the later part of this year and in 2027 and see promising early indications. However, we are also mindful of short-term demand constraints due to geopolitical and trade-related effects.

Let me highlight 3 topics that we will continue to prioritize in 2026. We will continue to actively drive measures to structurally reduce costs by rigorously implementing our cost savings programs, and we will bring down CapEx significantly below the level of depreciation. In parallel, we will hunt for volumes to increase the utilization rates of our plants. And after the successful start-up of our new Verbund site in China, it’s now all about filling the asset’s increasing utilization rates. Based on our highly competitive cost position, we are confident that we will achieve this goal fairly quickly.

Furthermore, we will focus on the completion of the final phase of the MDI capacity expansion in Geismar to capture further profitable growth in North America. And we will build on our successful portfolio measures to crystallize and unlock the value of our stand-alone businesses. We will stay on course to further strengthen our core businesses by implementing the necessary measures.

In summary, delivering on our Winning Ways strategy means combining active portfolio steering with capital discipline and strong operational execution when it comes to CapEx and costs. And this way, we will create value for our company.

Bernd Freytag

[Interpreted] Regarding Ludwigshafen, one follow-up question. So what range is the loss? And what do you expect this year? Second question, Mr. Elvermann, when you ask tariffs to be back, how much have you paid here, to give us an idea? Mr. Kamieth, regarding the European chemicals policy in general. The EU with the critical chemical alliance would like to pick value chains which may be protected or are seen as worth to continue, may probably be subsidized. What are you hoping for here?

Markus Kamieth
CEO & Chairman of the Board of Executive Directors

[Interpreted] Very complex questions. Let me start with chemicals, legislation, EU. Maybe you can take over then. Complicated issue, Mr. Freytag. Let me limit myself to Critical Chemicals Alliance. Otherwise, so many other topics will be added that are decided for us in Brussels. Critical Chemicals Alliance, developed from 2 different types of motivation. It’s an initiative by the EU Commission. On the one hand, the shock after corona, because we realized in many value chains, Europe is not in a robust situation. And if we don’t watch out, we will lose more value chains in Europe, and we will become even more dependent on other regions or even individual countries. Buzzword, rare earths. Buzzword, antibiotics. During COVID, it turned out, oh, it’s not a good thing to be in that weak situation in Europe.

Secondly, a short-term aspect, and that’s the import pressure that we experienced from the U.S. and from China regarding the chemical industry in Europe, because they put capacities in Europe under pressure. I say we caused this problem, of course, to a large extent, because competitiveness situation is very difficult here. So I welcome this approach. The industry, the EU Commission and many advisers want to sit down and discuss how can we come up with a regulatory framework to make sure that on the one hand, we maintain the European chemical industry. And on the other hand, we do away with the critical dependencies.

But I think we must not switch it in a way to come up with an island solution for Europe. We must not have a protectionist development in the chemical industry in Europe. That would be the wrong development. This is why we say we need a balanced approach where protection is necessary for reasons of resilience or, maybe in some cases, in a targeted way for competitive reasons. We are in favor. If it means that it will help, it’s okay. But if it continues with noncompetitive situations in Europe, we are against.

As a chemical industry in Europe, we don’t want to live in a zoo. We want to still live out in the wild. So my appeal to the EU Commission often is do not come up with too many specific aid packages, just make sure you take away the load from our shoulders, so that we can continue breathing. So that’s my approach here. But of course, I could spend hours discussing this.

Unknown Attendee

[Interpreted] Mr. Kamieth, in today’s press release, we read that last year, the Zhanjiang-Verbund site was started up successfully. It’s the third biggest production site of BASF globally. Why is BASF continuing to invest so much money in China? Looking at today’s uncertain times, how important is the Chinese market in the global strategic approach of BASF?

Markus Kamieth
CEO & Chairman of the Board of Executive Directors

[Interpreted] Thank you for the question. Yes, you are right. In the fourth quarter, so with the highlight of the steam cracker very early in January, we, from our point of view, successfully started up the site. As I said, 32 production assets were started up within only 4 weeks. And I would say, looking at the complexity and the success, I’m only talking about the technical start-up, not the construction, which was also great. But to achieving this with such a quality, I think this is the first ever in the chemical industry. So great performance by the team. And this goes to show that this is what our workforce really, really is able to do. We are very proud of this.

Of course, this does not protect us against a very difficult market in China. I said, well, the market is growing. There is volume growth in China. However, prices are under enormous pressure because of high overcapacities in China. This does not only go for the chemical industry. In China, for 40 months in a row, we have producer price inflation. So this producer price inflation is not what the consumer sees, but what the producing industry sees, and there is a strong margin pressure because of this in all Chinese industry. But we think in the mid to long term, this will be a successful site for BASF because the strategic location is fine in South China, in the Guangdong Province, where the heart of Chinese growth is to be found, and we are very competitive.

China represents almost 54% of the global chemical market. We are at the right location, with the right assets, with a site which, especially within China, but also at global level is producing with a very, very low CO2 footprint. So strategically speaking, very good. Operationally, in the short term, more difficult than expected. But still, we are convinced that this was the right decision. Even though in ’26, 2027, the financial performance will be a little more difficult.

In China, we generate around 13% of group sales of the BASF Group. This will increase slightly with the new site to between 15% and 20% probably, but China will become more important for us. And you have to put it in perspective. I tend to compare this with the U.S. The U.S. will still be a much bigger, much more important market than China in future. Sometimes the press says, well, we are somewhat biased here, but we are not.

Tom Brown

Just a quick one to close off. In light of the bearish environment this year and the insolvencies we’ve seen in Germany, especially, like do you have a projection on how much capacity you expect to leave the European market? And just kind of building from that, looking at Ursula von der Leyen’s comments in Antwerp and the delays in EU Mercosur as well as the delays to funding for Ukraine, do you think there’s an argument for centralizing greater power in Europe at the Brussels level?

Markus Kamieth
CEO & Chairman of the Board of Executive Directors

The second question, it’s a very fundamental question. I think if you would ask anybody in Europe, [indiscernible] form of the European Union and its constituents or processes, so to say, you would find a high vote. And I would say even people in the European Commission would say, yes, it would be needed because we are struggling with the 27 votes, 27 Unity votes on a lot of big decisions. But there’s also no easy answer. And I think, for me, it is not appropriate to now use the word like you used, centralization. It’s an oversimplification of what is needed.

Everybody wants to make Europe successful. We want to make Europe successful. We have to make Europe successful. I can only warn that especially parties that are making public noise around criticizing that the EU is maybe not good for Germany, that they don’t get, let’s say, too much airtime with their oversimplistic arguments, because Europe is good for us, Europe is good for European industry, Europe is good for most citizens in Europe, but we could use a more future-ready European Union, so to say, I would say. And I think there probably even Mrs. von der Leyen would subscribe to this. Your first question was on insolvencies…

Tom Brown

Yes, insolvencies…

Markus Kamieth
CEO & Chairman of the Board of Executive Directors

I don’t know. We have published this — the Cefic has published this in January. You have maybe seen this if you were in Antwerp, that over the last 3, 4 years, already 9% of the European chemical capacity has been closed with a consequence that 90,000 jobs have already been — direct and indirect jobs have been affected. And if you look at the dynamics, we are not at the end. So there is more capacity that will be closed. There are insolvencies, there’s restructuring. And I would say there’s also delayed restructuring now with some asset sales that are happening in Europe.

So I would say the time of restructuring in the European chemical industry is not yet over from a BASF perspective. This is also something we feel is necessary. So that’s why I said earlier, a protectionism in Europe is not good for the industry, and it’s also not good for BASF, because to some extent, the overcapacity also in Europe has to be addressed. The overcapacity is not only in China, it’s also in Europe.

And noncompetitive assets have to also be restructured. And we believe that this actually is a source of relative competitive advantage for BASF, because we have, in Europe, very competitive assets. In sites like Ludwigshafen and Antwerp, with a high degree of integration, a low cost base in terms of asset cost and good energy integration will actually play out their relative advantage compared to many other chemical sites in Europe, smaller nonintegrated that will get into difficulties.

https://seekingalpha.com/article/4876215-basf-se-basfy-q4-2025-press-conference-call-transcript?mailingid=44400311&messageid=2800&position=rta_analysis_rc2_news_popular_ticker_main_3_textlink&serial=44400311.538&source=email_2800